Asset
ADAGRASIB
Zai Lab Limited American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05263986 | phase1 | unknown | 2022-05-30 | 2023-10-31 | Zai Lab (Shanghai) Co., Ltd. | The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors |
FDA applications (0)
This company has no applications containing this asset.